Skip to main content

Alzheimer’s Therapeutics Market Area And Industry Forecasts Till, 2014 - 2025

Alzheimer’s disease is a progressive, non-reversible, and neurodegenerative disorder. Alzheimer is caused due to abnormal functioning of brain cells. It is the most common form of dementia. In simple words, it is a biological disease marked by physical changes in the brain and most remarkably build-up of small protein clumps called “Tangles” and “Plaques” that lead to the death of nerve cells.

The factors that propel the growth of the Alzheimer’s therapeutics market include well-developed healthcare infrastructure, high consciousness levels, increase in incidence of neurodegenerative diseases, growing aged population, and increasing R&D investment. On the other hand, there are factors that may hamper the growth of the market including lack of transparent reimbursements, high cost of treatment and diagnosis in the later stage, typically owing to delayed appearance of symptoms.

Download Free Sample  - https://www.millioninsights.com/industry-reports/alzheimers-therapeutics-market/request-sample

The new product launches and research collaborations are some of the key strategies adopted by the top industry players. For instance, Actavis plc in collaboration with Adamas Pharmaceuticals Inc. lately publicized the US FDA approval of Namzaric, a fixed-dose combination of donepezil and memantine. The drug is likely to be launched in the first half of year 2015. Additionally, in Jan 2015, Johnson & Johnson signed a research deal with a Swiss biotech firm AC Immune, to change anti-tau Alzheimer's vaccines.

Alzheimer’s therapeutics industry is anticipated to expand at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. Alzheimer’s therapeutics market could be explored by therapeutic type, application and geography. The market could be explored by therapeutic type as N-methyl-D-aspartate (NMDA) receptor antagonist and Cholinesterase Inhibitors. The “Cholinesterase Inhibitors” segment led the Alzheimer’s therapeutics industry in 2016 and is anticipated to maintain its dominance by 2024. The key applications that could be explored in the Alzheimer’s therapeutics market include Moderate to severe Stages, and Early to Moderate Stages.

North America accounted for the major share of the Alzheimer’s therapeutics industry in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing prevalence of Alzheimer’s disease, growing aged population, extensive technological advancements in the region, high awareness levels, and strong healthcare infrastructure. North America is likely to be followed by Europe.

Comments

Post a Comment

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...
Post a Comment
Read more

Which are the biggest markets (regions) for Insulin Pen?

    The global Insulin Pen market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Insulin Pen from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Insulin Pen market. Download Free Sample  -  https://www.radiantinsights.com/research/2013-2028-report-on-global-insulin-pen-market/request-sample Leading players of Insulin Pen including: Novo Nordisk Sanofi-Aventis Eli Lilly OWEN Mumford WOCKHARDT Dongbao(YPSOMED) Gan & Lee Market split by Type, can be divided into: Reusable Insulin Pen Disposable Insulin Pen Market split by Application, can be divided into: Hospitals Clinics The Chemist's Shops Market sp...
Post a Comment
Read more

Asthma Market Current Scenario And Industry Forecasts Till, 2014 - 2025

Asthma Market size such as the patent expiry of drugs, high expenditure on treatment, and growth in the use of generic drugs. The global Asthma Market size spans type, device type, drug type, route of administration, and geography. Based on type, the global Asthma Market size constitutes allergic asthma and non-allergic asthma. Allergic asthma is caused due to exposure to allergens like pollens from weeds, trees, etc., dust, and so on. On the other hand, non-allergic asthma is caused due to exercise, stress, cold, flu, etc. Download Free Sample  -  https://www.millioninsights.com/industry-reports/asthma-market/request-sample Based on device type, the global Asthma Market size constitutes inhalers and nebulizers. The “inhalers” segment is further sub-categorized as dry powder, soft mist inhalers (SMIs), metered-dose inhalers (MDIs). Nebulizers are devices that carry the drug in a fluid form that is dispensed by compressed air. The “nebulizers” segment is further sub-categorized...
Post a Comment
Read more